Syntheses and Preparations of Narwedine and Related Novel Compounds
AssigneeMedichem, S.A.
InventorsGabriel Tojo Suarez, Ernesto Duran Lopez, Jordi Bosch I Llado
Life of this patent
Estimating the term…
Abstract
The present invention relates to a process for preparing racemic narwedine (which can be can be kinetically resolved) to yield (−)-narwedine and which is the biogenic precursor of (−)-galanthamine) and the use thereof as a starting material for producing (−)-galanthamine. The invention further includes processes for preparing (−)-galanthamine and (−)-galanthamine hydrobromide, as well as related novel compounds.
Claims37
A process for preparing 1-bromo-12-oxo-narwedine (Compound 5) comprising treating 2-bromo-5-hydroxy-N-[2-(4-hydroxyphenyl)ethyl]-4-methoxy-N-methylbenzamide (Compound 4) with potassium hexacyanoferrate (III) as an oxidant in conjunction with less than approximately 10 molar equivalents of at least one base.
1-bromo-4a,5,9,10-tetrahydro-6-hydroxy-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]-benzazepin-12(9H)-one (Compound 6).
1-bromo-12-oxo-lycoramine.
(canceled)
(canceled)
(−)-Narwedine.BF3.
(−)-Galanthamine.BF3.
30-36. (canceled)
A process for preparing dehydroxygalanthamine comprising hydrolyzing tri-sec-butylborate in the presence of (−)-galanthamine.BF3.
(canceled)
40-43. (canceled)
A process for preparing epigalanthamine comprising epirimizing galanthamine under acidic conditions.
Dependencies are inferred from the claim text.